Sat Feb 07 15:51:25 UTC 2026: # Hyderabad Poised to Lead India’s Biologics and Next-Generation Therapy Revolution
The Story
Hyderabad, a major pharmaceutical hub in India, has the potential to lead the country in the biologics and next-generation therapy revolution. This assertion was made by M. Madan Mohan Reddy, Director of Aurobindo Pharma, during the 14th convocation ceremony at Jawaharlal Nehru Technological University Hyderabad (JNTUH) on February 7, 2026. Reddy emphasized the need for strengthened translational research, specialized manufacturing clusters, and multi-discipline scientific collaborations. He also highlighted the importance of adopting integrated computational science and fostering joint research programs to establish India as a green pharma hub.
Key Points
- M. Madan Mohan Reddy advocated for strengthening translational research and establishing specialized manufacturing clusters in Hyderabad.
- Reddy called for the adoption of integrated computational science for drug development and real-world evidence generation.
- JNTUH conferred 82,547 degrees, including undergraduate, postgraduate, Pharm.D, and PhD degrees.
- JNTUH reported successful campus placements with salary packages ranging from ₹4 lakh to ₹50 lakh.
- JNTUH developed 23 deep tech startups in cybersecurity and urban mobility.
- JNTUH received ₹10.65 crore in research funding from various government agencies.
Critical Analysis
The announcement comes at a time when India’s T20 World Cup performance shows a “huge net run-rate lead over Pakistan,” indicating a time of expansion and success for India, which may explain the drive for excellence in the pharma industry.
Key Takeaways
- Hyderabad is strategically positioned to become a global leader in biologics and next-generation therapies.
- Collaboration between industry, academia, and government is crucial for driving innovation in the pharmaceutical sector.
- Adopting advanced technologies like AI and computational science is essential for drug discovery and development.
- Investing in research and development is critical for India to become a global epicenter of bio innovation.
Impact Analysis
The focus on biologics and next-generation therapies could lead to significant advancements in healthcare, making treatments more effective and accessible. Establishing Hyderabad as a green pharma hub would also have a positive impact on the environment. The strong emphasis on research and development, coupled with the creation of deep tech startups, suggests a long-term commitment to innovation and economic growth in the region. The success of JNTUH graduates indicates a strong pipeline of talent to support these initiatives.
First Piper 